Clinical trial is a crucial and significant step to evaluate the safety and effectiveness of a medical strategy, treatment, or device for commercial usage. These studies also help understand and determine the best medical approaches for a particular therapeutic area. Clinical trials are conducted primarily to collect data regarding the safety and efficacy of new drug and device development. Before the approval of drug molecules or medical devices by the regulatory authorities, a series of clinical studies are conducted. The increasing prevalence of various communicable and noncommunicable diseases is creating the need for the development of new drugs or medical devices, which is, in turn, propelling the demand for the medical device & diagnostics contract research organization.
This report contains market size and forecasts of Medical Device and Diagnostics Contract in Global, including the following market information:
Global Medical Device and Diagnostics Contract Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Medical Device and Diagnostics Contract market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Medical Devices Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Medical Device and Diagnostics Contract include PAREXEL International Corporation, ICON PLC, WUXI APPTEC, Charles River Laboratories, Laboratory Corporation of America Holdings, North American Science Associates, Inc., Qserve Group B.V., IQVIA and Proxima Clinical Research, Inc. and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Medical Device and Diagnostics Contract companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Medical Device and Diagnostics Contract Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Medical Device and Diagnostics Contract Market Segment Percentages, by Type, 2021 (%)
Medical Devices
Diagnostics
Global Medical Device and Diagnostics Contract Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Medical Device and Diagnostics Contract Market Segment Percentages, by Application, 2021 (%)
Clinical Data Management
Monitoring
Clinical Project Management
Medical Writing
Clinical Auditing
Digital Health
Clinical Strategy
Others
Global Medical Device and Diagnostics Contract Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Medical Device and Diagnostics Contract Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Medical Device and Diagnostics Contract revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Medical Device and Diagnostics Contract revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
PAREXEL International Corporation
ICON PLC
WUXI APPTEC
Charles River Laboratories
Laboratory Corporation of America Holdings
North American Science Associates, Inc.
Qserve Group B.V.
IQVIA
Proxima Clinical Research, Inc.
Activa CRO